131I-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 4, 2008, Pages 725-733

  Gedik, Gonca Kara ^a   Hoefnagel, Cornelis A ^b   Bais, Evert ^b   Valdés Olmos, Renato A ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

131I MIBG; Malignant; Paraganglioma; Phaeochromocytoma; Radionuclide therapy

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; ANTIHYPERTENSIVE AGENT; POTASSIUM IODIDE; RADIOPHARMACEUTICAL AGENT; (3 IODOBENZYL)GUANIDINE; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BONE MARROW SUPPRESSION; CANCER INHIBITION; CANCER RADIOTHERAPY; CHEMOTHERAPY; CLINICAL ARTICLE; DIARRHEA; DIZZINESS; DRUG RESPONSE; FEMALE; FOLLOW UP; HEART PALPITATION; HUMAN; MALE; MALIGNANT PHEOCHROMOCYTOMA; MEDICAL RECORD REVIEW; METASTASIS; MULTIPLE CYCLE TREATMENT; MYELODYSPLASIA; NAUSEA; NEUTROPENIA; NEUTROPHIL; PARAGANGLIOMA; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDY; SIDE EFFECT; SYMPTOM; THROMBOCYTE; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR VOLUME; ADRENAL TUMOR; COMPUTER ASSISTED TOMOGRAPHY; MIDDLE AGED; MORTALITY; RADIOGRAPHY; SURVIVAL; THORAX TUMOR;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; ADULT; ANTINEOPLASTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PARAGANGLIOMA; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THORACIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 40949146144     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0652-6     Document Type: Article

References (14)

1. Yeo H, Roman S. Pheochromocytoma and functional paraganglioma. Curr Opin Oncol 2005;17:13-8.
2. Chan FK, Choi KL, Tiu SC, Shek CC, Yong TK, Au Yong TK. A case of giant malignant phaeochromocytoma. Hong Kong Med J 2000;6:325-8.
3. Averbuch SD, Steakley CS, Young RC, Gelmann EP, Goldstein DS, Stull R, Keiser HR. Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine and dacarbazine. Ann Intern Med 1988;109:267-73.
4. Hoefnagel CA. Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumors. Eur J Nucl Med 1994;21:561-81.
5. 111In Octreotide uptake in benign and malignant pheochromocytomas. Clin Endocrinol Metab 2001;86:685-93.
6. Ackery DM, Troncone L. Session on the role of [131I] metaiodobenzylguanidine in the treatment of malignant phaeochromocytoma. Chairmen's report. J Nucl Biol Med 1991;34:318-20.
7. 131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 1997;20:648-58.
8. Forssell-Aronson E, Bernhardt P, Wangberg B, Kolby L, Nilsson O, Ahlman H. Aspects of radionuclide therapy in malignant pheochromocytomas. Ann N Y Acad Sci 2006;1073:498-504.
9. Sisson JC, Frager MS, Valk TW, Gross MD, Swanson DP, Wieland DM, et al. Scintigraphic localization of pheochromocytoma. N Engl J Med 1981;305:12-7.
10. Sisson JC, Shapiro B, Beierwaltes WH, Glowniak JV, Nakajo M, Mangner TJ, et al. Radiopharmaceutical treatment of malignant pheochromocytoma. J Nucl Med 1984;25:197-206.
11. 131I-mIBG). Clin Endocrinol (Oxf) 2001;55:47-60.
12. Safford SD, Coleman RE, Gockerman JP, Moore J, Feldman JM, Leight GS Jr, et al. Iodine-131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery 2003;134:956-62.
13. 131I-Metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer 2003;98:239-48.
14. 131I-meta-iodo benzylguanidine kinetics in malignant phaeochromocytoma. Eur J Nucl Med 1988;14:345-8.